ACM
PCVX icon

Aquatic Capital Management’s Vaxcyte PCVX Stock Holding History

Aquatic Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$808K Buy
+13,907
New +$755K 0.03% 626
2026
Q1 		– Sell
-24,485
Closed -$1.13M – 1704
2025
Q4 		$1.13M Sell
24,485
-101,300
-81% -$4.53M 0.03% 516
2025
Q3 		$4.53M Sell
125,785
-80,386
-39% -$2.66M 0.08% 291
2025
Q2 		$6.7M Buy
+206,171
New +$6.76M 0.14% 196
2025
Q1 		– Sell
-28,501
Closed -$2.33M – 1550
2024
Q4 		$2.33M Buy
+28,501
New +$2.83M 0.06% 343

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Aquatic Capital Management's PCVX Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Vaxcyte (PCVX) in Q2 2026: 13,907 shares worth $808K. The stake represents 0.03% of the portfolio and ranks #626 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in PCVX as recently as Q4 2025.

Aquatic Capital Management first reported a position in PCVX in Q4 2024 and has held it in 5 quarters since. The position peaked at $6.7M in Q2 2025. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Aquatic Capital Management held 13,907 shares of Vaxcyte worth $808K as of Q2 2026.
  • Vaxcyte was a new Aquatic Capital Management position in Q2 2026.
  • Vaxcyte made up 0.03% of Aquatic Capital Management's portfolio in Q2 2026, its #626 holding.
  • Aquatic Capital Management first reported a position in Vaxcyte in Q4 2024 and has held it in 5 quarters since.
  • Aquatic Capital Management's Vaxcyte position peaked at $6.7M in Q2 2025.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.